Interval cancers in the Dutch breast cancer screening programme

British Journal of Cancer

Volumn 81, Issue 5, 1999, Pages 912-917

  Fracheboud, J ^a   De Koning, H J ^a   Beemsterboer, P M M ^a   Boer, R ^a   Verbeek, A L M ^b   Hendriks, J H C L ^b   Van Ineveld, B M ^a   Broeders, M J M ^b   De Bruyn, A E ^a   Van Der Maas, P J ^a  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^b RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

Author keywords

Breast cancer; Evaluation; Interval cancer; Population based screening; Proportionate incidence

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER INCIDENCE; CANCER INVASION; CANCER REGISTRY; CANCER SCREENING; CARCINOMA IN SITU; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MEDICAL RECORD; NETHERLANDS; PRIORITY JOURNAL; TUMOR VOLUME; UNITED KINGDOM;

AGED; BREAST NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, DUCTAL, BREAST; FEMALE; GREAT BRITAIN; HUMANS; INCIDENCE; MASS SCREENING; MIDDLE AGED; NEOPLASM STAGING; NETHERLANDS; REGISTRIES; TIME FACTORS;

EID: 0032750178     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6690786     Document Type: Article

References (25)

1. Akker-van Marle ME van den, Koning HJ de, Boer R and Maas PJ van der (1999) Reduction in breast cancer mortality due to the introduction of mass screening in the Netherlands; comparison with the UK. J Med Screening 6: 30-34
2. Boer R, Koning HJ de, Threlfall A, Warmerdam P. Street A, Friedman E and Woodman C (1998) Cost effectiveness of shortening screening interval or extending age range of NHS breast screening programme: computer simulation study. Br Med J 317: 376-379
3. Brekelmans CTM, Collette HJA, Collette C, Fracheboud J and Waard F de (1992) Breast cancer after a negative screen: follow-up of women participating in the DOM screening programme. Eur J Cancer 28A: 893-895
4. Day N, McCann J, Camilleri Ferrante C, Britton P, Hurst G, Cush S, Duffy S on behalf of the Quality Assurance Management Group of the East Anglian Breast Screening Programme (1995) Monitoring interval cancers in breast screening programmes: the East Anglian experience. J Med Screening 2: 180-185
5. Faux AM, Richardson DC, Lawrence GM, Wheaton ME and Wallis MG (1997) Interval breast cancers in the NHS Breast Screening Programme: does the current definition exclude too many? J Med Screening 4: 169-173
6. Fracheboud J, Koning HJ de, Beemsterboer PMM, Boer R, Hendriks JHCL, Verbeek ALM, Ineveld BM van. Bruyn AE de and Maas PJ van der (1998) Nation wide breast cancer screening in the Netherlands: results of initial and subsequent screening 1990-1995. Int J Cancer 75: 694-698
7. Garvican L and Littlejohns P (1996) An evaluation of the prevalent round of the breast screening programme in South East Thames, 1988-1993: achievement of quality standards and population impact. J Med Screening 3: 123-128
8. Klemi PJ, Toikkanen S, Räsänen O, Parvinen I and Joensuu H (1997) Mammography screening interval and the frequency of interval cancers in a population-based screening. Br J Cancer 75(5): 762-766
9. Koning HJ de, Ineveld BM van, Oortmarssen GJ van, Haes JCJM de, Collette HJA, Hendriks JHCL and Maas PJ van der (1991) Breast cancer screening and cost-effectiveness: policy alternatives, quality of life considerations and the possible impact of uncertain factors. Int J Cancer 49: 531-537
10. Koning HJ de, Fracheboud J, Boer R, Verbeck ALM, Collette HJA, Hendriks JHCL, Ineveld BM van, Bruyn AE and PJ van der Maas (National Evaluation Team for Breast cancer screening) (1995a). Nation-wide breast cancer screening in the Netherlands: support for breast-cancer mortality reduction. Int J Cancer 60: 777-780
11. Koning HJ de, Boer R, Wannerdam PG, Beemsterboer PMM and Maas PJ van der (1995b) Quantitative interpretation of age specific mortality reductions from the Swedish breast cancer screening trial. J Natl Cancer Inst 87: 1217-1223
12. Moss SM, Coleman DA, Ellman R, Chamberlain J, Forrest APM, Kirkpatrick AE, Thomas BA and Price JL (1993) Interval cancers and sensitivity in the screening centres of the UK trial of early detection of breast cancer. Eur J Cancer 29A: 225-258
13. Moss SM, Michel M, Patnick J, Johns L, Blanks R and Chamberlain J (1995) Results from the NHS breast screening programme 1990-1993. J Med Screening 2: 186-190
14. Nab HW, Voogd AC, Crommelin MA, Kluck HM, Heijden LH van der and Coebergh JWW (1993). Breast cancer in south-east Netherlands, 1960-1989: trends in incidence and mortality. Eur J Cancer 29A: 1557-1560
15. NETB - National Evaluation Team for Breast cancer screening (1995) National evaluation of breast cancer screening in the Netherlands (IV). Rotterdam: Department of Public Health, Erasmus University Rotterdam (in Dutch)
16. NETB - National Evaluation Team for Breast cancer screening (1997) National evaluation of breast cancer screening in the Netherland (VI). Rotterdam; Department of Public Health, Erasmus University Rotterdam (in Dutch, with summary in English)
17. NCR - Netherlands Cancer Registry (1992) Incidence of cancer in the Netherlands 1989 SIG Health Care Information, Utrecht
18. Ooflmarssen GJ van, Habbema JDF, Maas PJ van der, Koning HJ de, Collette HJA, Verbeck ALM, Geerts AT and Lubbe KTN (1990) A model for breast cancer screening. Cancer 66: 1601-1612
19. Pecters PHM, Verbeck ALM, Hendriks JHCL, Holland R, Mravunae M and Vooijs GP (1989) The occurrence of interval cancers in the Nijmegen screening programme. Br J Cancer 59: 929-932
20. Prior P, Woodman CBJ, Wilson S and Threlfall AG (1996) Reliability of underlying incidence rates for estimating the effect and efficiency of screening for breast cancer. J Med Screening 3: 119-122
21. Schouten LJ, Rijke JM de, Schlangen JT and Verbeck ALM (1998) Evaluation of the effect of breast cancer screening by record linkage with the cancer registry, the Netherlands. J Med Screening 5: 37-41
22. Sylvester PA, Davies JD, Vipond MN, Webb AJ, Kutt E and Farndon JR (1997) A comparative audit of prevalent, incident and interval cancers in the Avon breast screening programme. Ann R Coll Surg Engl 79: 272-275
23. Tabár L, Faberberg G, Day NE and Holmberg L (1987) What is the optimum interval between mammographic screening examinations? An analysis based on the latest results of the Swedish two-county breast cancer screening trial. Br J Cancer 55: 547-551
24. Vitak B, Stål O, Mänson JC, Thomas BA, Arnesson LG, Ekelund L, Mâre K, Nordenskjöld B, Källström AC and Bâng H (1997) Interval cancers and cancers in non-attenders in the Östergötland mammographic screening programme. Duration between screening and diagnosis, S-phase fraction and distant recurrence. Eur J Cancer 33: 1453-1460
25. Woodman CBJ, Threlfall AG, Boggis CRM and Prior P (1995) Is the three-year breast screening interval too long? Occurrence of interval cancers in NHS breast screening programmer's north western region. Br Med J 310: 224-226